Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
Title:
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
Author:
Faivre-Finn, Corinne Snee, Michael Ashcroft, Linda Appel, Wiebke Barlesi, Fabrice Bhatnagar, Adityanarayan Bezjak, Andrea Cardenal, Felipe Fournel, Pierre Harden, Susan Le Pechoux, Cecile McMenemin, Rhona Mohammed, Nazia O'Brien, Mary Pantarotto, Jason Surmont, Veerle Van Meerbeeck, Jan P Woll, Penella J Lorigan, Paul Blackhall, Fiona
Appeared in:
Lancet oncology
Paging:
Volume 18 (2017) nr. 8 pages 1116-1125
Year:
2017
Contents:
Publisher:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC-BY 4.0 license